WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
74.00
0.00 (0.00%)
At close: Dec 5, 2025

WeLeader Biomedical Revenue

WeLeader Biomedical had revenue of 295.89M TWD in the quarter ending September 30, 2025, with 15.79% growth. This brings the company's revenue in the last twelve months to 1.06B, up 9.05% year-over-year. In the year 2024, WeLeader Biomedical had annual revenue of 991.13M with 5.36% growth.

Revenue (ttm)
1.06B
Revenue Growth
+9.05%
P/S Ratio
3.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024991.13M50.43M5.36%
Dec 31, 2023940.70M-95.02M-9.17%
Dec 31, 20221.04B194.58M23.13%
Dec 31, 2021841.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition